Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × ALT-803 × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 2 Lymphoma, B-Cell 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Platinum-resistant Ovarian Cancer 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Melanoma 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡